These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25959115)

  • 1. Formulation factors affecting acceptability of oral medicines in children.
    Liu F; Ranmal S; Batchelor HK; Orlu-Gul M; Ernest TB; Thomas IW; Flanagan T; Kendall R; Tuleu C;
    Int J Pharm; 2015 Aug; 492(1-2):341-3. PubMed ID: 25959115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population.
    Venables R; Batchelor H; Hodson J; Stirling H; Marriott J
    Int J Pharm; 2015 Mar; 480(1-2):55-62. PubMed ID: 25601436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of acceptability of oral paediatric medicines: a review.
    Mistry P; Batchelor H;
    J Pharm Pharmacol; 2017 Apr; 69(4):361-376. PubMed ID: 27524471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation of medicines for children.
    Nunn T; Williams J
    Br J Clin Pharmacol; 2005 Jun; 59(6):674-6. PubMed ID: 15948931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-appropriate and acceptable paediatric dosage forms: Insights into end-user perceptions, preferences and practices from the Children's Acceptability of Oral Formulations (CALF) Study.
    Ranmal SR; Cram A; Tuleu C
    Int J Pharm; 2016 Nov; 514(1):296-307. PubMed ID: 27863675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient acceptability, safety and access: A balancing act for selecting age-appropriate oral dosage forms for paediatric and geriatric populations.
    Walsh J; Ranmal SR; Ernest TB; Liu F
    Int J Pharm; 2018 Feb; 536(2):547-562. PubMed ID: 28705619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory perspectives on acceptability testing of dosage forms in children.
    Kozarewicz P
    Int J Pharm; 2014 Aug; 469(2):245-8. PubMed ID: 24704104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral formulation of choice for children].
    Lajoinie A; Henin E; Kassai B
    Arch Pediatr; 2015 Aug; 22(8):877-85. PubMed ID: 26141805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to administering non-oral formulations in a paediatric population: A semi-structured interview study.
    Venables R; Batchelor H; Stirling H; Marriott J
    Int J Pharm; 2016 Jan; 497(1-2):12-7. PubMed ID: 26611666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosage form suitability in vulnerable populations: A focus on paracetamol acceptability from infants to centenarians.
    Ruiz F; Vallet T; Dufaÿ Wojcicki A; Belissa É; Fontan JE; de Pontual L; Nathanson S; Chevallier A; Laribe-Caget S; Boudy V
    PLoS One; 2019; 14(8):e0221261. PubMed ID: 31430323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of caregivers of Nigerian children less than 6 years of age to determine the experience and perception of acceptability of oral solid dosage forms.
    Orubu S; Okwelogu C; Opanuga O; Tuleu C
    Int J Pharm; 2018 Feb; 536(2):582-589. PubMed ID: 29100913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orodispersible drug formulations for children and elderly.
    Slavkova M; Breitkreutz J
    Eur J Pharm Sci; 2015 Jul; 75():2-9. PubMed ID: 25736528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability of different oral dosage forms in paediatric patients in hospital setting.
    Pokharkar V; Sajith M; Vallet T; Akshantal S; Shah R; Ruiz F; Salunke S
    Arch Dis Child; 2022 Sep; 107(9):796-801. PubMed ID: 34799375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations.
    Liu F; Ranmal S; Batchelor HK; Orlu-Gul M; Ernest TB; Thomas IW; Flanagan T; Tuleu C
    Drugs; 2014 Oct; 74(16):1871-1889. PubMed ID: 25274536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European perspectives on pediatric formulations.
    Breitkreutz J
    Clin Ther; 2008 Nov; 30(11):2146-54. PubMed ID: 19108802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric formulation issues identified in Paediatric Investigation Plans.
    Quijano Ruiz B; Desfontaine E; Arenas-López S; Wang S
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):25-30. PubMed ID: 24308789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of swallowability and palatability of oral dosage forms in children: Report from an M-CERSI pediatric formulation workshop.
    Ternik R; Liu F; Bartlett JA; Khong YM; Thiam Tan DC; Dixit T; Wang S; Galella EA; Gao Z; Klein S
    Int J Pharm; 2018 Feb; 536(2):570-581. PubMed ID: 28844897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral transmucosal drug delivery for pediatric use.
    Lam JK; Xu Y; Worsley A; Wong IC
    Adv Drug Deliv Rev; 2014 Jun; 73():50-62. PubMed ID: 23999459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.
    Walsh J; Cram A; Woertz K; Breitkreutz J; Winzenburg G; Turner R; Tuleu C;
    Adv Drug Deliv Rev; 2014 Jun; 73():14-33. PubMed ID: 24614069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.